Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor

被引:53
|
作者
Abdul-Ridha, Alaa [1 ]
Lopez, Laura [1 ]
Keov, Peter [1 ]
Thal, David M. [1 ]
Mistry, Shailesh N. [1 ,2 ]
Sexton, Patrick M. [1 ]
Lane, J. Robert [1 ]
Canals, Meritxell [1 ]
Christopoulos, Arthur [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[2] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
Allosteric Regulation; Drug Discovery; G Protein-coupled Receptors (GPCR); Molecular Dynamics; Site-directed Mutagenesis; Muscarinic Acetylcholine Receptor; PROTEIN-COUPLED RECEPTOR; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; GPCR ACTIVATION; CNS DISORDERS; FORCE-FIELD; AMINO-ACIDS; LIGAND; AGONISM; COMPLEX;
D O I
10.1074/jbc.M113.539080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: BQCA is a selective allosteric modulator of the M-1 mAChR. Results: Residues that govern BQCA activity were identified using mutagenesis and molecular modeling. Conclusion: BQCA likely occupies a pocket overlapping prototypical mAChR modulators and gains selectivity through cooperativity with orthosteric ligands. Significance: Understanding the structural basis of BQCA function can provide insight into the design of more tailored allosteric ligands. Benzylquinolone carboxylic acid (BQCA) is an unprecedented example of a selective positive allosteric modulator of acetylcholine at the M-1 muscarinic acetylcholine receptor (mAChR). To probe the structural basis underlying its selectivity, we utilized site-directed mutagenesis, analytical modeling, and molecular dynamics to delineate regions of the M-1 mAChR that govern modulator binding and transmission of cooperativity. We identified Tyr-85(2.64) in transmembrane domain 2 (TMII), Tyr-179 and Phe-182 in the second extracellular loop (ECL2), and Glu-397(7.32) and Trp-400(7.35) in TMVII as residues that contribute to the BQCA binding pocket at the M-1 mAChR, as well as to the transmission of cooperativity with the orthosteric agonist carbachol. As such, the BQCA binding pocket partially overlaps with the previously described common allosteric site in the extracellular vestibule of the M-1 mAChR, suggesting that its high subtype selectivity derives from either additional contacts outside this region or through a subtype-specific cooperativity mechanism. Mutation of amino acid residues that form the orthosteric binding pocket caused a loss of carbachol response that could be rescued by BQCA. Two of these residues (Leu-102(3.29) and Asp-105(3.32)) were also identified as indirect contributors to the binding affinity of the modulator. This new insight into the structural basis of binding and function of BQCA can guide the design of new allosteric ligands with tailored pharmacological properties.
引用
收藏
页码:6067 / 6079
页数:13
相关论文
共 50 条
  • [1] Allosteric Modulation of M1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking
    Yeatman, Holly R.
    Lane, J. Robert
    Choy, Kwok Ho Christopher
    Lambert, Nevin A.
    Sexton, Patrick M.
    Christopoulos, Arthur
    Canals, Meritxell
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (22) : 15856 - 15866
  • [2] Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor
    Espinoza-Fonseca, LM
    Trujillo-Ferrara, JG
    [J]. FEBS LETTERS, 2005, 579 (30) : 6726 - 6732
  • [3] Regulation of the M1 muscarinic acetylcholine receptor by orthosteric and allosteric ligands
    Thomas, R.
    Langmead, C.
    Wood, M.
    Challiss, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 28 - 28
  • [4] Development of a Photoactivatable Allosteric Ligand for the M1 Muscarinic Acetylcholine Receptor
    Davie, Briana J.
    Sexton, Patrick M.
    Capuano, Ben
    Christopoulos, Arthur
    Scammells, Peter J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2014, 5 (10): : 902 - 907
  • [5] Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor
    Jakubík, J
    Tucek, S
    El-Fakahany, EE
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1033 - 1041
  • [6] Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
    Ma, Lei
    Seager, Matthew
    Wittmann, Marion
    Jacobson, Marlene
    Bickel, Denise
    Burno, Maryann
    Jones, Keith
    Graufelds, Valerie Kuzmick
    Xu, Guangping
    Pearson, Michelle
    McCampbell, Alexander
    Gaspar, Renee
    Shughrue, Paul
    Danziger, Andrew
    Regan, Christopher
    Flick, Rose
    Pascarella, Danette
    Garson, Susan
    Doran, Scott
    Kreatsoulas, Constantine
    Veng, Lone
    Lindsley, Craig W.
    Shipe, William
    Kuduk, Scott
    Sur, Cyrille
    Kinney, Gene
    Seabrook, Guy R.
    Ray, William J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) : 15950 - 15955
  • [7] Differential Regulation of the M1 Muscarinic Acetylcholine Receptor by Orthosteric and Allosteric Ligands
    Thomas, Rachel
    Langmead, Christopher
    Wood, Martyn
    Challiss, John
    [J]. FASEB JOURNAL, 2008, 22
  • [8] Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
    Mistry, Shailesh N.
    Lim, Herman
    Joerg, Manuela
    Capuano, Ben
    Christopoulos, Arthur
    Lane, J. Robert
    Scammells, Peter J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2016, 7 (05): : 647 - 661
  • [9] Synthesis and pharmacological evaluation of irreversible allosteric ligands for the M1 muscarinic acetylcholine receptor
    Davie, B. J.
    Valant, C.
    Capuano, B.
    Scammells, P. J.
    Christopoulos, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S287 - S288
  • [10] Low allosteric agonism and moderate modulation are required for optimal therapeutic window for positive allosteric modulators of the M1 muscarinic acetylcholine receptor
    Nguyen, Huong Thi Mai
    van der Westhuizen, Emma
    Khajehali, Elham
    Christopoulos, Arthur
    Valant, Celine
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 411 - 412